Cost: Entirely Free
Developer: Risk Medical Solutions
Cost: Entirely Free
The Diabetic Retinopathy Calculator (DRC) is designed for individuals with diabetes and it is the first mobile application available developed specifically for diabetic retinopathy. The application allows users to track and monitor their disease progression and get valuable information about their clinical condition.Read More
The Risk DRC calculates patient’s percentage risk of developing sight-threatening retinopathy over time. The risk estimates are based on each individual’s clinical data. Find whether you are in high or low risk for developing retinopathy. Find out what you should do to lower your risk and achieve target levels Track and monitor your disease progression over time Find educational information about diabetic retinopathy and related diseases See recommended interval until your next screening visit A score of recommendations is given based on each individual result. The recommendation may be used to improve the health of each individual. The application provides the option of logging results over time to view and monitor progression over time. We recommend that this application be used every time an individual visits his endocrinologists or when they go for a screening visit. The company behind The Risk DRC application Risk Medical Solutions is an academic based software house located in Iceland with over 30 years of experience in screening for diabetic retinopathy and treating diabetes. DISCLAIMER: Please read the terms set out in this disclaimer. By accepting these terms and conditions you agree to this disclaimer and are deemed to be bound thereby in any event. This disclaimer covers all use of Risk Diabetic Retinopathy Calculator mobile application (Risk DRC). This mobile application is solely a decision support device and should always be used as such. The outcome should be viewed as relevant information or recommendation but not as a final decision as made by a health-care professional. It is always up to a licensed health-care professional to make the final decision for future intervals of screening visits. Developers (Risk Medical Solution, Dattaca Labs, Onymos Inc and Digi.me) are not liable for any damages or claims set forth by users based on the usage of the application. We do not warrant that the mobile application will meet your particular requirements or that the mobile application will run uninterrupted or error free. Please see further information on our company and products on www.retinarisk.com NOTE: This RetinaRisk app requires DigiMe app (available in AppStore) to access personal health-care data to use with advanced features of this RetinaRisk app. None of your data is 'touched', 'seen' or 'held' anywhere outside of your mobile device by this RetinaRisk app.
It was assessed as a Level 4 App. These Apps can be focused on general health or specific conditions and contain advanced and complex features that are subject to formal regulation. Where they collect data we assess their data use policies and compliance with relevant standards. Because they are health focused we also assess their compliance in the Clinical Assurance as well as the User Experience domains.
This App does collect data and it is therefore assessed and scored based on its performance in all the sections of our review.
We have identified that this App provides the following key features:
Social Support Networks
This App achieved an ORCHA score of 88%.
The data collected about you is capable of identifying that it relates to you
The type of data that it collects is classified as sensitive data.
The App does allow you to share information in the App with other Apps, systems, organisations or users.
The App doesn't encrypt the information it collects to make it safe from other people as it is transferred from the App.
The App doesn't encrypt the information it collects to make it safe from other people as it is retained by the the developer.
(Identifiable and Sensitive) - Because of the type of data that this App collects it is particularly important that the App takes the security and privacy of that data seriously and only enables others to see or share this information if you have expressly consented to this.
It was clear from our review that a suitably qualified professional or organisation was involved in the Apps development.
It was clear from our review how regularly the advice and guidance given by the App was reviewed and updated by relevant professionals.
It was clear from our review that the App had been involved in any clinical trials or similar testing to demonstrate its 'real world' effectiveness.
It was clear from our review that the App had been through end user testing as part of its design and development.
The App does provide customisable features.
End user capacity
The App does provide support for users with poor sight.
The App does provide support for users with hearing difficulties.
The App does appear to have a clear approach to dealing with user issues.
The App is entirely free to use.